𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroepidemiology. Part II: Assessment of therapeutic trials

✍ Scribed by Dr John F. Kurtzke

Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
849 KB
Volume
19
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Animal models of muscle diseases, part I
Animal models of muscle diseases, part III: Compilation of therapeutic trials for hereditary muscular dystrophy
✍ Dr. Ethel Cosmos; Jane Butler πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

One of the features of the IVth International Congress on Neuromuscular Diseases, held in Montreal September 17-21, 1978, was a series of invited posters. In order to achieve a wider audience for this valuable material, we have made arrangements to publish a number of these posters in Muscle €3 Nerv

Population-scale assessment endpoints in
Population-scale assessment endpoints in ecological risk assessment part II: Selection of assessment endpoint attributes
✍ Wayne G Landis; Laurel A Kaminski πŸ“‚ Article πŸ“… 2007 πŸ› Society of Environmental Toxicology and Chemistry 🌐 English βš– 118 KB

## Abstract Because ecological services often are tied to specific species, the risk to populations is a critical endpoint and important feature of ecological risk assessments. In Part 1 of this series it was demonstrated that population scale assessment endpoints are important expressions of the v